Lymphodepleting Total Body Irradiation (TBI) Plus Cyclophosphamide Prior to Ciltacabtagene Autoleucel (Carvykti; Cilta-cel) for Multiple Myeloma (MM) Patients With Impaired Renal Function
Clinical trial NCT06623630 · RECRUITING
Trial details
- NCT number
- NCT06623630
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-04
- Primary completion
- 2027-06-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.